Literature DB >> 8094402

Use of proliferation cell nuclear antigen immunoreactivity for distinguishing hydropic abortions from partial hydatidiform moles.

U R Suresh1, R J Hale, H Fox, C H Buckley.   

Abstract

AIMS: To determine whether the expression of proliferating cell nuclear antigen (PCNA) in villous cytotrophoblast could distinguish between placental tissue from a hydropic abortion and that from a partial hydatidiform mole.
METHODS: Tissue from 18 partial hydatidiform moles, 15 hydropic abortions, five normal first trimester placentas and five normal full term placentas were immunostained for expression of PCNA, using the monoclonal antibody PC10.
RESULTS: PCNA immunoreactivity was very much higher in the cytotrophoblast of normal first trimester placentas than in normal term placentas. Villous tissue from partial hydatidiform moles showed, on average, less immunoreactivity for PCNA than did villous tissue from hydropic abortions.
CONCLUSIONS: Immunostaining for PCNA is of no value for differentiating between partial hydatidiform moles and hydropic abortions. The findings indicate that trophoblastic proliferation or hyperplasia is not a feature of partial hydatidiform moles.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094402      PMCID: PMC501113          DOI: 10.1136/jcp.46.1.48

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

1.  [Regional different cell-proliferation in placetones (materno-fetal circulation-units) of mature human placenta (author's transl)].

Authors:  G Geier; R Schuhmann; H Kraus
Journal:  Arch Gynakol       Date:  1975

2.  Discrepancies in the histological diagnosis of hydatidiform mole.

Authors:  H Javey; G Borazjani; S Behmard; F A Langley
Journal:  Br J Obstet Gynaecol       Date:  1979-06

3.  Inter- and intra-pathologist variability in the diagnosis of gestational trophoblastic neoplasia.

Authors:  M L Messerli; T Parmley; J D Woodruff; A M Lilienfeld; L Bevilacqua; N B Rosenshein
Journal:  Obstet Gynecol       Date:  1987-04       Impact factor: 7.661

Review 4.  Pathology of the placenta.

Authors:  H Fox
Journal:  Clin Obstet Gynaecol       Date:  1986-09

5.  Statistics on microcomputers. A non-algebraic guide to their appropriate use in biomedical research and pathology practice. 3. Analysis of variance and distribution-free methods.

Authors:  R A Brown; J S Beck
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

6.  Flow cytometry in the assessment of human placental growth.

Authors:  O E Iversen; T Farsund
Journal:  Acta Obstet Gynecol Scand       Date:  1985       Impact factor: 3.636

7.  Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis.

Authors:  R L Garcia; M D Coltrera; A M Gown
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

8.  Involvement of proliferating cell nuclear antigen (cyclin) in DNA replication in living cells.

Authors:  M Zuber; E M Tan; M Ryoji
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

9.  Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta.

Authors:  R Bravo; R Frank; P A Blundell; H Macdonald-Bravo
Journal:  Nature       Date:  1987 Apr 2-8       Impact factor: 49.962

10.  Autoantibody to the proliferating cell nuclear antigen neutralizes the activity of the auxiliary protein for DNA polymerase delta.

Authors:  C K Tan; K Sullivan; X Y Li; E M Tan; K M Downey; A G So
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

View more
  2 in total

1.  Assessment of cell proliferation in hydatidiform mole using monoclonal antibody MIB1 to Ki-67 antigen.

Authors:  A N Cheung; H Y Ngan; R J Collins; Y L Wong
Journal:  J Clin Pathol       Date:  1994-07       Impact factor: 3.411

2.  Can histopathologists reliably diagnose molar pregnancy?

Authors:  A J Howat; S Beck; H Fox; S C Harris; A S Hill; C M Nicholson; R A Williams
Journal:  J Clin Pathol       Date:  1993-07       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.